Reply - 10/08/11
Doi : 10.1016/j.jaci.2010.10.057
David Price, FRCGP a, c 
, Richard J. Martin, MD d, Neil Barnes, MBBS, FRCP e, Paul Dorinsky, MD f, Elliot Israel, MD g, Nicolas Roche, MD, PhD h, Alison Chisholm, MSc c, Elizabeth V. Hillyer, DVM c, Linda Kemp, BSc c, Amanda J. Lee, PhD b, Julie von Ziegenweidt c, Gene Colice, MD i
, Richard J. Martin, MD d, Neil Barnes, MBBS, FRCP e, Paul Dorinsky, MD f, Elliot Israel, MD g, Nicolas Roche, MD, PhD h, Alison Chisholm, MSc c, Elizabeth V. Hillyer, DVM c, Linda Kemp, BSc c, Amanda J. Lee, PhD b, Julie von Ziegenweidt c, Gene Colice, MD i a Centre of Academic Primary Care, University of Aberdeen, Aberdeen, United Kingdom
b Section of Population Health, University of Aberdeen, Aberdeen, United Kingdom
c Research in Real Life, Norwich, United Kingdom
d National Jewish Health, Denver, Colo
e London Chest Hospital, London, United Kingdom
f Teva Global Respiratory Research and Development, Horsham, Pa
g Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass
h Hôtel-Dieu, Paris, France
i Washington Hospital Center and George Washington University School of Medicine, Washington, DC
Le texte complet de cet article est disponible en PDF.
| Access to data from the General Practice Research Database was supported by Merck & Co, Inc, and the analysis was supported by Teva Pharmaceuticals Ltd. |
|
| Disclosure of potential conflict of interest: D. Price for is on the advisory panel for and has received lecture fees and grants from GlaxoSmithKline and TEVA; is on the advisory panel and has received lecture fees from Merck and Boehringer Ingelheim; has received grants from Novartis; is director of Optimum Patient Care Ltd and Research in Real Life Ltd; has received research support from MSD; is a guideline group member of ARIA and EPOS; and is on the research committee for the International Primary Care Respiratory Group. R. J. Martin is a consultant for TEVA, Novartis/Genentech, Schering, Cypress BioScience, Phase to Phase and Common Health, and AstraZeneca and has received research support from the National Institutes of Health, National Heart, Lung, and Blood Institute. N. Barnes is a consultant for GlaxoSmithKline, AstraZeneca, Chiesi, Boehringer Ingelheim, TEVA, and Nycomed and has received research support from GlaxoSmithKline, Novartis, and Schering-Plough. P. Dorinsky is employed by TEVA. E. Israel is a consultant for Abbott, Amgen, Cowen & Co, GlaxoSmithKline, Icagen, MedImmune, Merck, NewMentor, NKT Therapeutics, Ono Pharmaceuticals US, Pulmatrix, Schering-Plough, and TEVA; has received research support from Aerovance, Amgen, Ception Therapeutics, Genentech, Icagen, MedImmune, National Institutes of Health, and Novartis; and has provided expert witness testimony on the topic of asthma. N. Roche has received consulting fees from GlaxoSmithKline, AstraZeneca, Boehringer Ingelheim, Pfizer, Chiesi, Novartis, Nycomed, TEVA, MEDA, and Mundi Pharma. A. Chisholm has received research support from TEVA. E. V. Hillyer has received fees for freelance writing from Merck, TEVA, and Aerocrine. L. Kemp has declared that she has no conflicts of interest. A. J. Lee has received research support from Research in Real Life. J. von Ziegenweidt has received research support from TEVA. G. Colice has received fees for consulting, advising, and speaking from TEVA, GlaxoSmithKline, Boehringer Ingelheim, Pfizer, and Merck. |
© 2010
American Academy of Allergy, Asthma & Immunology. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 127 - N° 3
P. 835-836 - mars 2011 Retour au numéro
Article précédent
- Asthma control differences between inhaled corticosteroids likely related to differences in patient severity
- Richard H. Stanford, Steven W. Yancey, David A. Stempel
- Supplementation with cow’s milk at birth is not recommended
- Sibylle Koletzko, Birgit Filipiak-Pittroff, Andrea von Berg, Armin Grübl, Joachim Heinrich, Ursula Krämer, H.-Erich Wichmann, Carl-Peter Bauer, Dietrich Reinhardt, Dietrich Berdel, German Infant Nutritional Intervention Study Group
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?